NYSE American - Delayed Quote USD

Chromocell Therapeutics Corporation (CHRO)

Compare
0.7299 +0.0344 (+4.95%)
At close: 3:59 PM EDT

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current6/30/20243/31/2024
Market Cap 4.01M 7.61M 15.11M
Enterprise Value 3.19M 8.78M 16.29M
Trailing P/E -- -- --
Forward P/E -- -- --
PEG Ratio (5yr expected) -- -- --
Price/Sales -- -- --
Price/Book 4.11 6.74 --
Enterprise Value/Revenue -- -- --
Enterprise Value/EBITDA -3.58 -- --
3/31/2024 - 2/16/2024

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 6/30/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -412.80%
Return on Equity (ttm) --

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA --
Net Income Avi to Common (ttm) -9.79M
Diluted EPS (ttm) -1.6800
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 2.41M
Total Cash Per Share (mrq) 0.42
Total Debt (mrq) 1.59M
Total Debt/Equity (mrq) --
Current Ratio (mrq) 0.93
Book Value Per Share (mrq) -0.03

Cash Flow Statement

Operating Cash Flow (ttm) -5.56M
Levered Free Cash Flow (ttm) -6.49M

Trading Information

Stock Price History

Beta (5Y Monthly) --
52 Week Range 3 -85.50%
S&P 500 52-Week Change 3 39.07%
52 Week High 3 6.0000
52 Week Low 3 0.5200
50-Day Moving Average 3 0.8011
200-Day Moving Average 3 1.6425

Share Statistics

Avg Vol (3 month) 3 113.56k
Avg Vol (10 day) 3 312.12k
Shares Outstanding 5 5.77M
Implied Shares Outstanding 6 5.77M
Float 8 1.33M
% Held by Insiders 1 80.76%
% Held by Institutions 1 9.43%
Shares Short (9/30/2024) 4 31.67k
Short Ratio (9/30/2024) 4 0.24
Short % of Float (9/30/2024) 4 0.73%
Short % of Shares Outstanding (9/30/2024) 4 0.55%
Shares Short (prior month 8/30/2024) 4 21.83k

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers